These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

56 related items for PubMed ID: 3284095

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR, Nevill TJ, Balshaw RF, Toze CL, Corr T, Currie CJ, Strong DK, Keown PA.
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [Abstract] [Full Text] [Related]

  • 4. How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
    Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.
    Clin Transplant; 1998 Oct; 12(5):379-90. PubMed ID: 9787945
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
    Jaksch P, Kocher A, Neuhauser P, Sarahrudi K, Seweryn J, Wisser W, Klepetko W.
    J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
    [Abstract] [Full Text] [Related]

  • 7. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
    Hmiel SP, Canter C, Shepherd R, Lassa-Claxton S, Nadler M.
    Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions.
    Knoop C, Vervier I, Thiry P, De Backer M, Kovarik JM, Rousseau A, Marquet P, Estenne M.
    Transplantation; 2003 Aug 27; 76(4):683-8. PubMed ID: 12973109
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation.
    Wacke R, Kundt G, Gock M, Klar E, Drewelow B, Schareck W.
    Transplant Proc; 2006 Apr 27; 38(3):751-2. PubMed ID: 16647462
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine challenge in the decision of combined kidney-pancreas versus solitary pancreas transplantation.
    Brennan DC, Stratta RJ, Lowell JA, Miller SA, Taylor RJ.
    Transplantation; 1994 Jun 15; 57(11):1606-11. PubMed ID: 8009595
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
    Simonson SG, Raza A, Martin PD, Mitchell PD, Jarcho JA, Brown CD, Windass AS, Schneck DW.
    Clin Pharmacol Ther; 2004 Aug 15; 76(2):167-77. PubMed ID: 15289793
    [Abstract] [Full Text] [Related]

  • 14. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR, Vanrenterghem Y.
    Clin Ther; 2004 Nov 15; 26(11):1834-44. PubMed ID: 15639695
    [Abstract] [Full Text] [Related]

  • 15. Single daily dose administration of cyclosporine in renal transplant recipients.
    Halim MA, Said T, Al-Otaibi T, Eleawa S, Al-Maged H, Gawish AE, Nair P, Al-Muzairai I, Nampoory MR, Al-Mousawi M.
    Transplant Proc; 2007 May 15; 39(4):1225-7. PubMed ID: 17524939
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent pharmacokinetics of cyclosporine (Neoral) in de novo renal transplant patients.
    Lukas JC, Suárez AM, Valverde MP, Calvo MV, Lanao JM, Calvo R, Suarez E, Gil AD.
    J Clin Pharm Ther; 2005 Dec 15; 30(6):549-57. PubMed ID: 16336287
    [Abstract] [Full Text] [Related]

  • 17. Analysis of United States (US) and non-US pancreas transplants reported to the United network for organ sharing (UNOS) and the international pancreas transplant registry (IPTR) as of October 2001.
    Gruessner AC, Sutherland DE.
    Clin Transpl; 2001 Dec 15; ():41-72. PubMed ID: 12211799
    [Abstract] [Full Text] [Related]

  • 18. Glipizide treatment of post-transplant diabetes does not interfere with cyclosporine pharmacokinetics in renal allograft recipients.
    Sagedal S, Asberg A, Hartmann A, Bergan S, Berg KJ.
    Clin Transplant; 1998 Dec 15; 12(6):553-6. PubMed ID: 9850449
    [Abstract] [Full Text] [Related]

  • 19. Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients.
    Cooney GF, Mochon M, Kaiser B, Dunn SP, Goldsmith B.
    Pharmacotherapy; 1995 Dec 15; 15(3):353-6. PubMed ID: 7667170
    [Abstract] [Full Text] [Related]

  • 20. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000.
    Gruessner AC, Sutherland DE.
    Clin Transpl; 2000 Dec 15; ():45-72. PubMed ID: 11512358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.